Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.09
(0.0%)
CAD 0.09
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 159.04 Million CAD | -17.85% |
| 2022 | 193.59 Million CAD | 1.84% |
| 2021 | 190.1 Million CAD | 52.47% |
| 2020 | 124.68 Million CAD | 25.03% |
| 2019 | 99.72 Million CAD | 5.92% |
| 2018 | 94.15 Million CAD | 404.83% |
| 2017 | 18.65 Million CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | -100.0% |
| 2006 | 112.42 Million CAD | -11.66% |
| 2005 | 127.26 Million CAD | 40.48% |
| 2004 | 90.59 Million CAD | 74.54% |
| 2003 | 51.9 Million CAD | 12.58% |
| 2002 | 46.1 Million CAD | 4.78% |
| 2001 | 44 Million CAD | -11.04% |
| 2000 | 49.46 Million CAD | 10.38% |
| 1999 | 44.81 Million CAD | 83.03% |
| 1998 | 24.48 Million CAD | 24.86% |
| 1997 | 19.6 Million CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 79.5 Million CAD | -2.72% |
| 2024 Q1 | 81.72 Million CAD | -48.61% |
| 2023 Q3 | 156.23 Million CAD | -18.61% |
| 2023 FY | 159.04 Million CAD | -17.85% |
| 2023 Q2 | 191.95 Million CAD | -0.45% |
| 2023 Q4 | 159.04 Million CAD | 1.8% |
| 2023 Q1 | 192.82 Million CAD | -0.4% |
| 2022 Q3 | 193.52 Million CAD | -0.39% |
| 2022 Q4 | 193.59 Million CAD | 0.04% |
| 2022 FY | 193.59 Million CAD | 1.84% |
| 2022 Q2 | 194.28 Million CAD | -1.0% |
| 2022 Q1 | 196.25 Million CAD | 3.23% |
| 2021 Q1 | 127.36 Million CAD | 2.15% |
| 2021 FY | 190.1 Million CAD | 52.47% |
| 2021 Q4 | 190.1 Million CAD | 64.54% |
| 2021 Q3 | 115.53 Million CAD | 1.7% |
| 2021 Q2 | 113.61 Million CAD | -10.8% |
| 2020 Q1 | 99.02 Million CAD | -0.7% |
| 2020 Q4 | 124.68 Million CAD | 8.51% |
| 2020 Q2 | 107.99 Million CAD | 9.05% |
| 2020 Q3 | 114.9 Million CAD | 6.41% |
| 2020 FY | 124.68 Million CAD | 25.03% |
| 2019 FY | 99.72 Million CAD | 5.92% |
| 2019 Q2 | 101.23 Million CAD | 0.77% |
| 2019 Q3 | 190.45 Million CAD | 88.14% |
| 2019 Q1 | 100.46 Million CAD | 6.7% |
| 2019 Q4 | 99.72 Million CAD | -47.64% |
| 2018 Q1 | 91.06 Million CAD | 388.29% |
| 2018 Q3 | 93.32 Million CAD | -0.09% |
| 2018 FY | 94.15 Million CAD | 404.83% |
| 2018 Q4 | 94.15 Million CAD | 0.88% |
| 2018 Q2 | 93.41 Million CAD | 2.57% |
| 2017 Q4 | 18.65 Million CAD | -27.97% |
| 2017 FY | 18.65 Million CAD | 0.0% |
| 2017 Q3 | 25.89 Million CAD | 2.75% |
| 2017 Q2 | 25.2 Million CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2007 Q2 | 100.87 Million CAD | -10.48% |
| 2007 Q1 | 112.68 Million CAD | 0.23% |
| 2007 Q4 | - CAD | -100.0% |
| 2007 Q3 | 80.19 Million CAD | -20.5% |
| 2007 FY | - CAD | -100.0% |
| 2006 Q3 | 120.98 Million CAD | -9.7% |
| 2006 Q4 | 112.42 Million CAD | -7.08% |
| 2006 Q2 | 133.98 Million CAD | 2.25% |
| 2006 Q1 | 131.02 Million CAD | 2.96% |
| 2006 FY | 112.42 Million CAD | -11.66% |
| 2005 Q3 | 101.38 Million CAD | 0.5% |
| 2005 Q1 | 96.8 Million CAD | 6.86% |
| 2005 Q4 | 127.26 Million CAD | 25.53% |
| 2005 FY | 127.26 Million CAD | 40.48% |
| 2005 Q2 | 100.88 Million CAD | 4.21% |
| 2004 Q2 | 66.51 Million CAD | 14.91% |
| 2004 Q3 | 69.53 Million CAD | 4.54% |
| 2004 Q4 | 90.59 Million CAD | 30.29% |
| 2004 FY | 90.59 Million CAD | 74.54% |
| 2004 Q1 | 57.88 Million CAD | 11.52% |
| 2003 FY | 51.9 Million CAD | 12.58% |
| 2003 Q4 | 51.9 Million CAD | 8.15% |
| 2003 Q2 | 47.03 Million CAD | 0.87% |
| 2003 Q3 | 47.99 Million CAD | 2.04% |
| 2003 Q1 | 46.63 Million CAD | 1.14% |
| 2002 Q2 | 45.36 Million CAD | 2.66% |
| 2002 FY | 46.1 Million CAD | 4.78% |
| 2002 Q4 | 46.1 Million CAD | 0.74% |
| 2002 Q3 | 45.76 Million CAD | 0.88% |
| 2002 Q1 | 44.19 Million CAD | 0.43% |
| 2001 Q2 | 43.01 Million CAD | -13.39% |
| 2001 Q1 | 49.66 Million CAD | 0.4% |
| 2001 Q3 | 43.06 Million CAD | 0.13% |
| 2001 FY | 44 Million CAD | -11.04% |
| 2001 Q4 | 44 Million CAD | 2.17% |
| 2000 Q3 | 44.32 Million CAD | -2.43% |
| 2000 FY | 49.46 Million CAD | 10.38% |
| 2000 Q1 | 45.35 Million CAD | 1.2% |
| 2000 Q4 | 49.46 Million CAD | 11.59% |
| 2000 Q2 | 45.43 Million CAD | 0.18% |
| 1999 Q3 | 41.94 Million CAD | 57.6% |
| 1999 Q2 | 26.61 Million CAD | -1.33% |
| 1999 Q4 | 44.81 Million CAD | 6.85% |
| 1999 FY | 44.81 Million CAD | 83.03% |
| 1999 Q1 | 26.97 Million CAD | 0.0% |
| 1998 FY | 24.48 Million CAD | 24.86% |
| 1998 Q2 | 25.45 Million CAD | -1.41% |
| 1998 Q1 | 25.81 Million CAD | 27.43% |
| 1997 Q4 | 20.25 Million CAD | 0.0% |
| 1997 FY | 19.6 Million CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | -51.774% |
| Avicanna Inc. | 1.8 Million CAD | -8719.19% |
| Avant Brands Inc. | 18.7 Million CAD | -750.417% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -100223.594% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | -12583.014% |
| Knight Therapeutics Inc. | 69.09 Million CAD | -130.196% |
| MediPharm Labs Corp. | 2.29 Million CAD | -6830.065% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -102509.677% |
| Canopy Growth Corporation | 683.17 Million CAD | 76.72% |
| Willow Biosciences Inc. | 2.15 Million CAD | -7276.855% |